batch purification
batch of biotherapeutic product
Process flexibility
Chromatographic purification
Biotherapeutic Manufacturing
use of single
FibroSelect eases process constraints
product capture
current bioprocessing platform technologies
processing opportunities
biotherapeutic manufacture
disposable system
disposable manner
processing costs
innovative bioprocessing platform technology
biopharmaâ€™s product pipeline
flexible disposable formats
new bioprocessing platforms
fusion proteins
high-productivity
biotherapeutics drugs
biosimilar industry
evolving industry
complexity of biotherapeutics
rapid growth
manufactured cost
cost reductions
large complex proteins
varying market demand
promising therapeutic opportunities
increasing price sensitivity of payers
bispecific antibodies
uncertainty
functionalised cellulose chromatography medium
viral vectors
drug development
cleaning columns
re-validating
requirement
global medicines
purifying ligand
Step-change
spending
diversity
limitation
facility utilisation
Puridify
accounting
FAST-BM
area
Challenges
point
innovation
CAGR
value